Asieris Receives NMPA IND Approval for APL-1401 in Ulcerative Colitis

The study is a randomized, double-blind Phase Ib study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of APL-1401 in patie...

August 30, 2023 | Wednesday | News
Johnson & Johnson Vision Launches ELITA™ Platform for Myopia Correction with SILK Procedure

Next-generation laser vision correction provides next-day results and recovery1,2 The next-generation ELITATM Fe...

August 30, 2023 | Wednesday | News
GE Introduces Vscan Air SL: Handheld Wireless Ultrasound for Quick Cardiac Assessments

With a dual-headed probe, the Vscan Air SL offers a sector array and a linear array on a single device which is ideal for switching between focused cardi...

August 28, 2023 | Monday | News
Biobot Analytics Launches Respiratory Illnesses Panel

Biobot Analytics, a global leader in wastewater intelligence, announced today that it is launching a Respiratory Illnesses Panel that will include concurre...

August 25, 2023 | Friday | News
Humana Expands Care for Chronic Kidney Disease with Interwell Health

Value-based care is a holistic, patient-centered healthcare model that focuses on a coordinated effort to help improve patient health outcomes and quality ...

August 24, 2023 | Thursday | News
Study Explores Masimo PVi® for Targeted Liquid Therapy in Elderly Surgical Patients

Researchers found that fluid therapy guided by non-invasive and continuous PVi can reduce cardiopulmonary complications and infusion.   Masimo (NASD...

August 22, 2023 | Tuesday | News
Bayer President, Sebastian Guth, Highlights Alarming Link: Rising Fear, Lack of Education, and Distrust Hinder Access to Vital Preventative Care

One in Four American Adults Would Rather Not Know They Have Cancer   A new study from The Harris Poll, commissioned by Bayer, suggests fear factors ...

August 22, 2023 | Tuesday | Analysis
Heart Failure Startup Acorai Advances Toward Regulatory Approval

Acorai is developing a first-of-its-kind, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for...

August 21, 2023 | Monday | News
3Z and biotx.ai Partner to Enhance ADHD Drug Development with AI Modeling

3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...

August 21, 2023 | Monday | News
Anika's Integrity™ Implant System Granted 510(k) Clearance for Rotator Cuff Repair Augmentation

Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure, resulting...

August 21, 2023 | Monday | News
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial inte...

August 18, 2023 | Friday | News
Propanc Targets First Human Study Site at Peter Mac Cancer Center, Australia

The Peter Mac Cancer Center is a world leading cancer research, education and treatment center and Australia’s only public health service dedicated t...

August 16, 2023 | Wednesday | News
MediciNova Granted New European Patent for Scleroderma Treatment MN-001

This patent is expected to expire no earlier than June 2035. The allowed claims cover the use of MN-001 (tipelukast) for inhibiting or treating sclero...

August 16, 2023 | Wednesday | News
Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Part...

August 15, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close